标题
Multitargeting nature of muscarinic orthosteric agonists and antagonists
作者
关键词
-
出版物
Frontiers in Physiology
Volume 13, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-09-06
DOI
10.3389/fphys.2022.974160
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Understanding Why Muscarinic Receptor Agonists Have Antipsychotic Properties
- (2022) Peter J. Weiden et al. CNS SPECTRUMS
- Kinetic Modeling of Time-Dependent Enzyme Inhibition by Pre-Steady-State Analysis of Progress Curves: The Case Study of the Anti-Alzheimer’s Drug Galantamine
- (2022) Doriano Lamba et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The unconventional activation of the muscarinic acetylcholine receptor M4R by diverse ligands
- (2022) Jingjing Wang et al. Nature Communications
- Dopamine and Dopamine-Related Ligands Can Bind Not Only to Dopamine Receptors
- (2022) Jaromir Myslivecek Life-Basel
- The activation of M2 muscarinic receptor inhibits cell growth and survival in human epithelial ovarian carcinoma
- (2022) Marilena Taggi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Dibenzodiazepinone-type muscarinic receptor antagonists conjugated to basic peptides: impact of the linker moiety and unnatural amino acids on M2R selectivity
- (2021) Corinna.G. Weinhart et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
- (2021) Wei-Yu Chen et al. Communications Biology
- Targeting muscarinic receptors to treat schizophrenia
- (2021) Daniel J. Foster et al. BEHAVIOURAL BRAIN RESEARCH
- Muscarinic M 4 and M 5 receptor subtypes in the ventral subiculum differentially modulate alcohol seeking vs consumption in male alcohol preferring rats
- (2021) Leigh C. Walker et al. BRITISH JOURNAL OF PHARMACOLOGY
- Muscarinic Acetylcholine Receptors in the Retina—Therapeutic Implications
- (2021) Yue Ruan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Guanidine Derivatives: How Simple Structural Modification of Histamine H3R Antagonists Has Led to the Discovery of Potent Muscarinic M2R/M4R Antagonists
- (2021) Marek Staszewski et al. ACS Chemical Neuroscience
- Identification of a Novel Allosteric Site at the M5 Muscarinic Acetylcholine Receptor
- (2021) Wessel A. C. Burger et al. ACS Chemical Neuroscience
- Multi-Target Directed Ligands (MTDLs) Binding the σ1 Receptor as Promising Therapeutics: State of the Art and Perspectives
- (2021) Francesca Serena Abatematteo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Muscarinic receptor binding activity in rat tissues by vibegron and prediction of its receptor occupancy levels in the human bladder
- (2021) Shizuo Yamada et al. INTERNATIONAL JOURNAL OF UROLOGY
- Potentiation of muscarinic M3 receptor activation through a new allosteric site with a novel positive allosteric modulator ASP8302
- (2021) Risa Okimoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Functionally selective and biased agonists of muscarinic receptors
- (2021) Alena Randáková et al. PHARMACOLOGICAL RESEARCH
- Update on PET Tracer Development for Muscarinic Acetylcholine Receptors
- (2021) Marius Ozenil et al. Pharmaceuticals
- Social Isolation: How Can the Effects on the Cholinergic System Be Isolated?
- (2021) Jaromir Myslivecek Frontiers in Pharmacology
- Priming of GABAergic Long-term Potentiation by Muscarinic Receptors
- (2020) Koyam Morales-Weil et al. NEUROSCIENCE
- Antidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA1
- (2020) Maria C. Olianas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Muscarinic Receptors, from Synaptic Plasticity to its Role in Network Activity
- (2020) D. Fernández de Sevilla et al. NEUROSCIENCE
- Brucine: A Review of Phytochemistry, Pharmacology, and Toxicology
- (2020) Lu Lu et al. Frontiers in Pharmacology
- Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia
- (2020) Brian Dean et al. PSYCHIATRY RESEARCH
- M3 but not M4 muscarinic receptors in the rostromedial tegmental nucleus are involved in the acquisition of morphine-induced conditioned place preference
- (2020) Jing Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Evaluation of 11C-LSN3172176 as a novel PET tracer for imaging M1 muscarinic acetylcholine receptors in non-human primates
- (2019) Nabeel B Nabulsi et al. JOURNAL OF NUCLEAR MEDICINE
- Allosteric Modalities for Membrane-Bound Receptors: Insights from Drug Hunting for Brain Diseases
- (2019) Quinn Coughlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, Optimization, and Biological Characterization of 2,3,6‐Trisubstituted Pyridine‐Containing M 4 Positive Allosteric Modulators
- (2019) Jeffrey W. Schubert et al. ChemMedChem
- Characterization of binding of antipsychotics to muscarinic receptors using mouse cerebral cortex
- (2019) Keisuke Obara et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes
- (2019) Shoji Maeda et al. SCIENCE
- Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
- (2019) Samira Ztaou et al. NEUROCHEMISTRY INTERNATIONAL
- 11-Aminostrychnine and N-(Strychnine-11-yl)propionamide: Synthesis, Configuration, and Pharmacological Evaluation at Glycine Receptors
- (2019) Darius P. Zlotos et al. JOURNAL OF NATURAL PRODUCTS
- Triazole derivatives as inhibitors of Alzheimer's disease: Current developments and structure-activity relationships
- (2019) Man Xu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Crystal structure of the M5muscarinic acetylcholine receptor
- (2019) Ziva Vuckovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders
- (2019) Sean P. Moran et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Probing the binding site of novel selective positive allosteric modulators at the M 1 muscarinic acetylcholine receptor
- (2018) Elham Khajehali et al. BIOCHEMICAL PHARMACOLOGY
- The discovery of VU0486846: steep SAR from a series of M 1 PAMs based on a novel benzomorpholine core
- (2018) Jeanette L. Bertron et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases
- (2018) Christian C. Felder et al. NEUROPHARMACOLOGY
- Allosteric modulators targeting CNS muscarinic receptors
- (2018) Andreas Bock et al. NEUROPHARMACOLOGY
- Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease
- (2018) E.P. Lebois et al. NEUROPHARMACOLOGY
- Distribution and function of the muscarinic receptor subtypes in the cardiovascular system
- (2018) Hannah C. Saternos et al. PHYSIOLOGICAL GENOMICS
- Chemical Diversity in the G Protein-Coupled Receptor Superfamily
- (2018) Márton Vass et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MK-7622: A First-in-Class M1 Positive Allosteric Modulator Development Candidate
- (2018) Douglas C. Beshore et al. ACS Medicinal Chemistry Letters
- The deletion of M4 muscarinic receptors increases motor activity in females in the dark phase
- (2018) Paulina Valuskova et al. Brain and Behavior
- Autoradiography of 3H-pirenzepine and 3H-AFDX-384 in Mouse Brain Regions: Possible Insights into M1, M2, and M4 Muscarinic Receptors Distribution
- (2018) Paulina Valuskova et al. Frontiers in Pharmacology
- Identification and pharmacological profile of SPP1, a potent, functionally selective and brain penetrant agonist at muscarinic M1 receptors
- (2018) Lisa M Broad et al. BRITISH JOURNAL OF PHARMACOLOGY
- Structural insights into the subtype-selective antagonist binding to the M2 muscarinic receptor
- (2018) Ryoji Suno et al. Nature Chemical Biology
- Carbachol Induces Phase-dependent Phase Shifts of Per1 Transcription Rhythms in Cultured Suprachiasmatic Nucleus Slices
- (2017) Kumiko Dojo et al. JOURNAL OF BIOLOGICAL RHYTHMS
- Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1)
- (2017) Eugene C. Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Characterization of PCS1055, a novel muscarinic M4 receptor antagonist
- (2016) Carrie H. Croy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Discovery of the Potent and Selective M1 PAM-Agonist N-[(3R,4S)-3-Hydroxytetrahydro-2H-pyran-4-yl]-5-methyl-4-[4-(1,3-thiazol-4-yl)benzyl]pyridine-2-carboxamide (PF-06767832): Evaluation of Efficacy and Cholinergic Side Effects
- (2016) Jennifer E. Davoren et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
- (2016) David M. Thal et al. NATURE
- The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT 3 receptors
- (2016) Martin Lochner et al. NEUROPHARMACOLOGY
- The ChEMBL database in 2017
- (2016) Anna Gaulton et al. NUCLEIC ACIDS RESEARCH
- Argininosuccinate lyase interacts with cyclin A2 in cytoplasm and modulates growth of liver tumor cells
- (2016) Yu-Hsuan Hung et al. ONCOLOGY REPORTS
- Arecoline inhibits intermediate-conductance calcium-activated potassium channels in human glioblastoma cell lines
- (2015) Edmund Cheung So et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors
- (2015) Monika Szabo et al. JOURNAL OF MEDICINAL CHEMISTRY
- The M2muscarinic receptors are essential for signaling in the heart left ventricle during restraint stress in mice
- (2015) Hana Tomankova et al. STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS
- Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling
- (2015) Loes E.M. Kistemaker et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Selective Activation of M4 Muscarinic Acetylcholine Receptors Reverses MK-801-Induced Behavioral Impairments and Enhances Associative Learning in Rodents
- (2014) Michael Bubser et al. ACS Chemical Neuroscience
- Discovery, Synthesis and Characterization of a Highly Muscarinic Acetylcholine Receptor (mAChR)-Selective M5-Orthosteric Antagonist, VU0488130 (ML381): A Novel Molecular Probe
- (2014) Patrick R. Gentry et al. ChemMedChem
- Mechanistic Insights into Allosteric Structure-Function Relationships at the M1Muscarinic Acetylcholine Receptor
- (2014) Alaa Abdul-Ridha et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of FDA-Approved Drugs as Inhibitors of Fatty Acid Binding Protein 4 Using Molecular Docking Screening
- (2014) Yan Wang et al. Journal of Chemical Information and Modeling
- Discovery, Biological Evaluation, and Crystal Structure of a Novel Nanomolar Selective Butyrylcholinesterase Inhibitor
- (2014) Boris Brus et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of a Highly Potent, Novel M5 Positive Allosteric Modulator (PAM) Demonstrating CNS Exposure: 1-((1H-Indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380)
- (2014) Patrick R. Gentry et al. JOURNAL OF MEDICINAL CHEMISTRY
- Muscarinic acetylcholine receptors: novel opportunities for drug development
- (2014) Andrew C. Kruse et al. NATURE REVIEWS DRUG DISCOVERY
- Prediction of Thorough QT study results using action potential simulations based on ion channel screens
- (2014) Gary R. Mirams et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- In vitro and in vivo evaluation of polymethylene tetraamine derivatives as NMDA receptor channel blockers
- (2013) Ryotaro Saiki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design, synthesis and binding affinity of acetylcholine carbamoyl analogues
- (2013) Cristiano Bolchi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: Emerging ‘Novel Psychoactive Drugs’
- (2013) Warunya Arunotayanun et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of ML326: The first sub-micromolar, selective M5 PAM
- (2013) Patrick R. Gentry et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of the First M5-Selective and CNS Penetrant Negative Allosteric Modulator (NAM) of a Muscarinic Acetylcholine Receptor: (S)-9b-(4-Chlorophenyl)-1-(3,4-difluorobenzoyl)-2,3-dihydro-1H-imidazo[2,1-a]isoindol-5(9bH)-one (ML375)
- (2013) Patrick R. Gentry et al. JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology – Foe or Friend?
- (2013) Jens-Uwe Peters JOURNAL OF MEDICINAL CHEMISTRY
- Abundance, distribution, mobility and oligomeric state of M2 muscarinic acetylcholine receptors in live cardiac muscle
- (2013) Tatiana A. Nenasheva et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Activation and allosteric modulation of a muscarinic acetylcholine receptor
- (2013) Andrew C. Kruse et al. NATURE
- Repeated Immobilization Stress Increases Expression of β3-Adrenoceptor in the Left Ventricle and Atrium of the Rat Heart
- (2013) Marcela Laukova et al. STRESS AND HEALTH
- Himbacine-Derived Thrombin Receptor Antagonists: C7-Aminomethyl and C9a-Hydroxy Analogues of Vorapaxar
- (2013) Mariappan V. Chelliah et al. ACS Medicinal Chemistry Letters
- Profile of blonanserin for the treatment of schizophrenia
- (2013) Tomomi Tenjin et al. Neuropsychiatric Disease and Treatment
- Targeting Selective Activation of M1 for the Treatment of Alzheimer’s Disease: Further Chemical Optimization and Pharmacological Characterization of the M1 Positive Allosteric Modulator ML169
- (2012) James C. Tarr et al. ACS Chemical Neuroscience
- Molecular Alliance-From Orthosteric and Allosteric Ligands to Dualsteric/Bitopic Agonists at G Protein Coupled Receptors
- (2012) Klaus Mohr et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Syntheses and in vitro evaluation of decalinvesamicol analogues as potential imaging probes for vesicular acetylcholine transporter (VAChT)
- (2012) Takashi Kozaka et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: The case of chelerythrine
- (2012) Gerda Brunhofer et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)isonicatinamide, ML293, as a novel, selective and brain penetrant positive allosteric modulator of the muscarinic 4 (M4) receptor
- (2012) James M. Salovich et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor
- (2012) Bruce J. Melancon et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An investigation into the structure–activity relationships associated with the systematic modification of the β2-adrenoceptor agonist indacaterol
- (2012) David Beattie et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of a selective M4 positive allosteric modulator based on the 3-amino-thieno[2,3-b]pyridine-2-carboxamide scaffold: Development of ML253, a potent and brain penetrant compound that is active in a preclinical model of schizophrenia
- (2012) Uyen Le et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Beta3 Adrenoceptors Substitute the Role of M2 Muscarinic Receptor in Coping with Cold Stress in the Heart: Evidence from M2KO Mice
- (2012) Jan Benes et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: Synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine
- (2012) Abdelouahid Samadi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment
- (2012) Barbara Wiśniowska et al. JOURNAL OF APPLIED TOXICOLOGY
- Fluorescent Derivatives of AC-42 To Probe Bitopic Orthosteric/Allosteric Binding Mechanisms on Muscarinic M1 Receptors
- (2012) Sandrine B. Daval et al. JOURNAL OF MEDICINAL CHEMISTRY
- The synthesis and receptor binding affinities of DDD-016, a novel, potential, atypical antipsychotic
- (2012) Achintya Bandyopadhyaya et al. MedChemComm
- Design-driven LO: The discovery of new ultra long acting dibasic β2-adrenoceptor agonists
- (2011) Stephen Connolly et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D2 and serotonin 5-HT1A receptors
- (2011) Peter Heusler et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A Monod-Wyman-Changeux Mechanism Can Explain G Protein-coupled Receptor (GPCR) Allosteric Modulation
- (2011) Meritxell Canals et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery
- (2011) Bruce J. Melancon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological Characterization of LY593093, an M1 Muscarinic Acetylcholine Receptor-Selective Partial Orthosteric Agonist
- (2011) M. L. Watt et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Allosteric Modulation of the M3 Muscarinic Receptor by Amiodarone and N-Ethylamiodarone: Application of the Four-Ligand Allosteric Two-State Model
- (2011) E. Stahl et al. MOLECULAR PHARMACOLOGY
- Demonstration of Muscarinic and Nicotinic Receptor Binding Activities of Distigmine to Treat Detrusor Underactivity
- (2010) Taketsugu Harada et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators
- (2010) Thomas M. Bridges et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- AE9C90CB: a novel, bladder-selective muscarinic receptor antagonist for the treatment of overactive bladder
- (2010) S Sinha et al. BRITISH JOURNAL OF PHARMACOLOGY
- Discovery ofN-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): An Allosteric Muscarinic M1Receptor Agonist with Unprecedented Selectivity and Procognitive Potential
- (2010) Anette G. Sams et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel Tacrine Derivatives with a Combination of Acetylcholinesterase Inhibition and Cannabinoid CB1Receptor Antagonism
- (2010) Jos H. M. Lange et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Non-Peptide Malignant Brain Tumor (MBT) Repeat Antagonists by Virtual Screening of Commercially Available Compounds
- (2010) Dmitri Kireev et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bivalent β-Carbolines as Potential Multitarget Anti-Alzheimer Agents
- (2010) Yvonne Rook et al. JOURNAL OF MEDICINAL CHEMISTRY
- Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules
- (2010) J. A. Hern et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemical lead optimization of a pan Gq mAChR M1, M3, M5 positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M5 PAM
- (2009) Thomas M. Bridges et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Quantitative analysis of the loss of muscarinic receptors in various peripheral tissues in M1-M5 receptor single knockout mice
- (2009) Yoshihiko Ito et al. BRITISH JOURNAL OF PHARMACOLOGY
- Agonist activity of N-desmethylclozapine at δ-opioid receptors of human frontal cortex
- (2009) Maria C. Olianas et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharmacological comparison of muscarinic ligands: Historical versus more recent muscarinic M1-preferring receptor agonists
- (2009) Julia N. Heinrich et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Discovery of the First Highly M5-Preferring Muscarinic Acetylcholine Receptor Ligand, an M5 Positive Allosteric Modulator Derived from a Series of 5-TrifluoromethoxyN-Benzyl Isatins
- (2009) Thomas M. Bridges et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, Activity, and Pharmacophore Development for Isatin-β-thiosemicarbazones with Selective Activity toward Multidrug-Resistant Cells
- (2009) Matthew D. Hall et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Quaternary Ammonium Derivatives of (3R)-Quinuclidinol Esters as Potent and Long-Acting Muscarinic Antagonists with Potential for Minimal Systemic Exposure after Inhaled Administration: Identification of (3R)-3-{[Hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane Bromide (Aclidinium Bromide)
- (2009) María Prat et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Novel Selective Muscarinic Acetylcholine Receptor Subtype 1 Antagonist Reduces Seizures without Impairing Hippocampus-Dependent Learning
- (2009) D. J. Sheffler et al. MOLECULAR PHARMACOLOGY
- The pharmacology of sigma-1 receptors
- (2009) Tangui Maurice et al. PHARMACOLOGY & THERAPEUTICS
- Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation
- (2009) L. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Potential utility of histamine H3 receptor antagonist pharmacophore in antipsychotics
- (2008) Y. von Coburg et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Characterization of a CNS penetrant, selective M1muscarinic receptor agonist, 77-LH-28-1
- (2008) C J Langmead et al. BRITISH JOURNAL OF PHARMACOLOGY
- Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: A comparative study of coupling to Gαs
- (2008) Delphine S. Dupuis et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors
- (2008) Stefania Butini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Requirements for Drug Inhibition of the Liver Specific Human Organic Cation Transport Protein 1
- (2008) Gustav Ahlin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Centrally Active Allosteric Potentiators of the M4 Muscarinic Acetylcholine Receptor Reverse Amphetamine-Induced Hyperlocomotor Activity in Rats
- (2008) A. E. Brady et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity
- (2008) J. E. Marlo et al. MOLECULAR PHARMACOLOGY
- The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles
- (2008) Jaromir Myslivecek et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease
- (2008) Abraham Fisher Neurotherapeutics
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now